Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Palliative Medicine
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Wilcock, A.
Right arrow Articles by Tattersfield, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcock, A.
Right arrow Articles by Tattersfield, A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Safety and efficacy of nebulized lignocaine in patients with cancer and breathlessness

A. Wilcock

City Hospital, Nottingham

R. Corcoran

Hayward House Macmillan Palliative Care Unit, Nottingham

AE Tattersfield

City Hospital, Nottingham

Although anecdotal reports suggest nebulized lignocaine may help breathlessness in patients with cancer this has not been examined formally. We report a pilot study comparing nebulized lignocaine 100 mg and 200 mg with saline in six patients with cancer who were breathless at rest. Nebulized lignocaine was well tolerated apart from mild bronchoconstriction in two patients after the 200 mg dose and the unpleasant taste; serum concentrations were below levels at which toxicity has been reported. The effort of breathing (measured on a visual analogue scale) did not differ between treatments, whereas the distress of breathing was less after saline than after either dose of lignocaine. These findings do not support the reported benefits of nebulized lignocaine.

Key Words: dyspnoea • lidocaine • neoplasms • palliative treatment • respiration disorders • terminal care

Palliative Medicine, Vol. 8, No. 1, 35-38 (1994)
DOI: 10.1177/026921639400800106
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 AM J HOSP PALLIAT CAREHome page
G. Zeppetella
The palliation of dyspnea in terminal disease
American Journal of Hospice and Palliative Medicine, November 1, 1998; 15(6): 322 - 330.
[Abstract] [PDF]

Home page
 Palliat MedHome page
G. Zeppetella
Nebulized morphine in the palliation of dyspnoea
Palliative Medicine, July 1, 1997; 11(4): 267 - 275.
[Abstract] [PDF]